The Cigna Group’s Evernorth recently shared plans for a rebate-free pharmacy benefit model. The move could simplify drug pricing, but leaders on Cigna’s Oct. 30 earnings call warned of some potential growing pains while adjusting to the change. “Our new…
Author: Elizabeth Casolo
The federal government has shut down for the first time since 2019 after lawmakers failed to reach a funding deal, with the fate of enhanced ACA subsidies, set to expire at year’s end, hanging in the balance. Premium tax credits…
New York City employees and retirees — coupled with advocacy group Hands Off NY Care — filed a lawsuit in response to the city’s expected transition to a self-funded health plan, according to an Oct. 29 court document. The new…
CVS Health President and CEO David Joyner highlighted Aetna’s “renewed vigor” during an Oct. 29 earnings call. Despite CVS’ $4 billion loss in the third quarter, the company’s healthcare benefits segment generated $36 billion in revenue, a 9% year-over-year boost.…
PacificSource will cut about 300 roles across Oregon, Idaho, Montana and Washington, according to a spokesperson and notices filed with the government. The payer cited a “significant” drop in Medicaid membership across Lane County, Ore., as a driving force behind…
Advertisement
The Cigna Group posted a $1.9 billion profit in 2025’s third quarter, up from $739 million during the same period last year, according to an Oct. 30 earnings release. Total revenue reached $69.7 billion, a 9.5% increase year over year,…
The ACA marketplace’s open enrollment period kicks off on Nov. 1, but HealthCare.gov and states have price previews already available. The shopping window will remain open until Jan. 15, 2026, but those assessing their coverage face uncertainty. The fate of…
Centene’s prescription drug plan enrollment is driving Medicare performance, contributing about half of the segment’s revenue, according to an Oct. 29 earnings call. Centene’s premium and service revenue reached $44.9 billion in the third quarter of 2025. Medicare prescription drug…
CVS Health boosted its guidance despite a $4 billion loss. The company documented $103 billion in revenue for third-quarter 2025, according to an Oct. 29 financial report. Revenue was up 7.8% year over year. The company raised its outlook and…
Centene reported a $6.6 billion loss in 2025’s third quarter but landed $49.7 billion in revenue, the company shared in its Oct. 29 earnings release. The company cited the One Big Beautiful Bill Act and a dip in its stock…